Scott Tagawa, M.D., Of Weill Cornell Medicine discusses Availability Of PSMA-617 Radionuclide Therapy. At ESMO Oncology Conference – Munich, Germany On October 19, 2018.
Availability Of PSMA-617 Radionuclide Therapy
Scott Tagawa, M.D., Of Weill Cornell Medicine discusses Availability Of PSMA-617 Radionuclide Therapy. At ESMO Oncology Conference – Munich, Germany On October 19, 2018.